Advances in Molecular Pathology, 2025
Series: Advances;
- Publisher's listprice EUR 170.99
-
70 918 Ft (67 541 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 13% (cc. 9 219 Ft off)
- Discounted price 61 699 Ft (58 761 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
70 918 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Health Sciences
- Date of Publication 27 November 2025
- ISBN 9780443429293
- Binding Hardback
- No. of pages pages
- Size 241x190 mm
- Weight 450 g
- Language English 674
Categories
Long description:
Advances in Molecular Pathology reviews the year’s most important findings and updates within the field in order to provide practitioners with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Ahmad Abou Tayoun, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in molecular pathology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.
- Contains 24 articles on such topics as advances in prenatal genomic sequencing; assay development for emerging viruses: how and when to offer testing; solid tumors; informatics; health disparities in precision medicine; the near future of modern cytogenetics: whole genome sequencing, long-read sequencing, or optical genome mapping?; and more
- Provides in-depth, clinical reviews in molecular pathology, providing actionable insights for clinical practice
- Presents the latest information in the field under the leadership of an experienced editorial team. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews
Table of Contents:
Advances in Inherited Bone Marrow Failure Syndromes: Clinical Manifestations, Genetics, and Diagnostic Approaches
Advances in Prenatal Genomic Sequencing
Role of Long-read Sequencing in Comprehensive Genomic Profiling of Hematolymphoid Malignancies
DNA Methylation-Based Profiling in Mature B-cell Neoplasms
Emerging Biomarkers in Non-small Cell Lung Cancer: ERBB2 and MET Amplifications
Perspectives on Homologous Recombination Repair Deficiency (HRD): Updates on Testing to Treatments
A Review of Molecular Techniques and Biomarkers for the Diagnosis of Tumors of the Central Nervous System
Economic Analysis of Pharmacogenomics: Challenges and Progress
A Beginner’s Guide to Assay Development for Emerging Pathogens
Current State of Metagenomics for Infectious Diseases Diagnosis: Limitations and Future Directions
Molecular Detection of Antimicrobial Resistance Markers, Clinical Application, and Limitations
Health Disparities and Precision Medicine
The Near Future of Cancer Cytogenetics: Whole Genome Sequencing, Long-Read Sequencing, or Optical Genome Mapping?
Economics of Molecular Pathology
